Bruker Corporation (BRKR) vs LivaNova PLC (LIVN)
- Bruker Corporation BRKR 60.69 +4.53%
- LivaNova PLC LIVN 90.77 −0.41%
Bruker Corporation and LivaNova PLC are both Medical Devices companies. Bruker Corporation is the larger, with a market value of $8.9B against $5.0B — 1.8× the size. Bruker Corporation has negative trailing earnings, so its P/E is not meaningful; LivaNova PLC trades at 25.6×. LivaNova PLC grew revenue faster over the last twelve months: 11.7% against 2.16%. LivaNova PLC has the higher net margin (13.0% vs −4.76%) and the higher return on invested capital (9.14% vs −1.12%). Across the 20 metrics below, LivaNova PLC leads on 12 and Bruker Corporation on 8.
Valuation
Profitability
| Metric | BRKR | LIVN | Medical Devices median |
|---|---|---|---|
| Gross margin | 47.66% | 67.84% | 57.76% |
| Operating margin | (1.99%) | 10.75% | (15.07%) |
| Net margin | (4.76%) | 13.01% | (14.45%) |
| Free cash flow margin | 6.97% | 9.05% | (3.88%) |
| Return on equity | (7.04%) | 15.50% | (10.35%) |
| Return on assets | (2.73%) | 7.44% | (17.26%) |
| Return on invested capital | (1.12%) | 9.14% | (5.27%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack